Switch theme
Sign up to access all valuation multiples
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
1971
70K+
LTM Revenue $13.3B
LTM EBITDA $2.2B
$24.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Labcorp has a last 12-month revenue of $13.3B and a last 12-month EBITDA of $2.2B.
In the most recent fiscal year, Labcorp achieved revenue of $13.0B and an EBITDA of $1.8B.
Labcorp expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Labcorp valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $12.2B | $13.0B | XXX | XXX | XXX |
| Gross Profit | $4.4B | $3.4B | XXX | XXX | XXX |
| Gross Margin | 36% | 26% | XXX | XXX | XXX |
| EBITDA | $1.3B | $1.8B | XXX | XXX | XXX |
| EBITDA Margin | 11% | 14% | XXX | XXX | XXX |
| Net Profit | $1.3B | $418M | XXX | XXX | XXX |
| Net Margin | 11% | 3% | XXX | XXX | XXX |
| Net Debt | $4.9B | $4.5B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Labcorp's stock price is $228.
Labcorp has current market cap of $19.1B, and EV of $24.8B.
See Labcorp trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $24.8B | $19.1B | XXX | XXX | XXX | XXX | $15.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Labcorp has market cap of $19.1B and EV of $24.8B.
Labcorp's trades at 1.9x LTM EV/Revenue multiple, and 11.1x LTM EBITDA.
Analysts estimate Labcorp's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Labcorp and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $24.8B | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 13.7x | XXX | XXX | XXX |
| P/E | 25.6x | XXX | XXX | XXX |
| P/E/Growth | 0.6x | XXX | XXX | XXX |
| EV/FCF | 22.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpLabcorp's NTM/LTM revenue growth is 6%
Labcorp's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $36K for the same period.
Over next 12 months, Labcorp's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Labcorp's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Labcorp and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 35% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 20% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $36K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 19% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Sonic Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Bangkok Dusit Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Labcorp acquired XXX companies to date.
Last acquisition by Labcorp was XXXXXXXX, XXXXX XXXXX XXXXXX . Labcorp acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Labcorp founded? | Labcorp was founded in 1971. |
| Where is Labcorp headquartered? | Labcorp is headquartered in United States of America. |
| How many employees does Labcorp have? | As of today, Labcorp has 70K+ employees. |
| Who is the CEO of Labcorp? | Labcorp's CEO is Mr. Adam H. Schechter. |
| Is Labcorp publicy listed? | Yes, Labcorp is a public company listed on NYS. |
| What is the stock symbol of Labcorp? | Labcorp trades under LH ticker. |
| When did Labcorp go public? | Labcorp went public in 1991. |
| Who are competitors of Labcorp? | Similar companies to Labcorp include e.g. Australian Clinical Labs, Healius, Integral Diagnostics, Sonic Healthcare. |
| What is the current market cap of Labcorp? | Labcorp's current market cap is $19.1B |
| What is the current revenue of Labcorp? | Labcorp's last 12-month revenue is $13.3B. |
| What is the current EBITDA of Labcorp? | Labcorp's last 12-month EBITDA is $2.2B. |
| What is the current EV/Revenue multiple of Labcorp? | Current revenue multiple of Labcorp is 1.9x. |
| What is the current EV/EBITDA multiple of Labcorp? | Current EBITDA multiple of Labcorp is 11.1x. |
| What is the current revenue growth of Labcorp? | Labcorp revenue growth between 2023 and 2024 was 7%. |
| Is Labcorp profitable? | Yes, Labcorp is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
